“…Further, there is no evidence that neurodevelopmental therapy, when applied in the first few months of life to infants at risk for CP (primarily low birth-weight infants), will prevent development of CP or otherwise alter neurodevelopmental outcome. However, a blanket statement labeling neurodevelopmental therapy ineffective is not possible due to the scope, weaknesses, and limitations of existing research [Tirosh and Rabino, 1989;Palmer, 1992;Bower, 1993;Turnbull, 1993;Graves, 1995;Hur, 1995;Harris, 1997;Pakula and Palmer, 1997]. Many of these limitations are inevitable.…”